M D Kruizinga1,2,3, N van der Heide1,2, A Moll1,2, A Zhuparris1, Y Yavuz1, M L de Kam1, F E Stuurman1,3, A F Cohen1,3, G J A Driessen2,4. 1. Centre for Human Drug Research, Leiden, The Netherlands. 2. Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands. 3. Leiden University Medical Centre, Leiden, The Netherlands. 4. Maastricht University Medical Centre, Maastricht, The Netherlands.
Abstract
BACKGROUND: Digital devices and wearables allow for the measurement of a wide range of health-related parameters in a non-invasive manner, which may be particularly valuable in pediatrics. Incorporation of such parameters in clinical trials or care as digital endpoint could reduce the burden for children and their parents but requires clinical validation in the target population. This study aims to determine the tolerability, repeatability, and reference values of novel digital endpoints in healthy children. METHODS: Apparently healthy children (n = 175, 46% male) aged 2-16 were included. Subjects were monitored for 21 days using a home-monitoring platform with several devices (smartwatch, spirometer, thermometer, blood pressure monitor, scales). Endpoints were analyzed with a mixed effects model, assessing variables that explained within- and between-subject variability. Endpoints based on physical activity, heart rate, and sleep-related parameters were included in the analysis. For physical-activity-related endpoints, a sample size needed to detect a 15% increase was calculated. FINDINGS: Median compliance was 94%. Variability in each physical activity-related candidate endpoint was explained by age, sex, watch wear time, rain duration per day, average ambient temperature, and population density of the city of residence. Estimated sample sizes for candidate endpoints ranged from 33-110 per group. Daytime heart rate, nocturnal heart rate and sleep duration decreased as a function of age and were comparable to reference values published in the literature. CONCLUSIONS: Wearable- and portable devices are tolerable for pediatric subjects. The raw data, models and reference values presented here can be used to guide further validation and, in the future, clinical trial designs involving the included measures.
BACKGROUND: Digital devices and wearables allow for the measurement of a wide range of health-related parameters in a non-invasive manner, which may be particularly valuable in pediatrics. Incorporation of such parameters in clinical trials or care as digital endpoint could reduce the burden for children and their parents but requires clinical validation in the target population. This study aims to determine the tolerability, repeatability, and reference values of novel digital endpoints in healthy children. METHODS: Apparently healthy children (n = 175, 46% male) aged 2-16 were included. Subjects were monitored for 21 days using a home-monitoring platform with several devices (smartwatch, spirometer, thermometer, blood pressure monitor, scales). Endpoints were analyzed with a mixed effects model, assessing variables that explained within- and between-subject variability. Endpoints based on physical activity, heart rate, and sleep-related parameters were included in the analysis. For physical-activity-related endpoints, a sample size needed to detect a 15% increase was calculated. FINDINGS: Median compliance was 94%. Variability in each physical activity-related candidate endpoint was explained by age, sex, watch wear time, rain duration per day, average ambient temperature, and population density of the city of residence. Estimated sample sizes for candidate endpoints ranged from 33-110 per group. Daytime heart rate, nocturnal heart rate and sleep duration decreased as a function of age and were comparable to reference values published in the literature. CONCLUSIONS: Wearable- and portable devices are tolerable for pediatric subjects. The raw data, models and reference values presented here can be used to guide further validation and, in the future, clinical trial designs involving the included measures.
Authors: M D Kruizinga; F E Stuurman; V Exadaktylos; R J Doll; D T Stephenson; G J Groeneveld; G J A Driessen; A F Cohen Journal: Pharmacol Rev Date: 2020-10 Impact factor: 25.468
Authors: James F Sallis; Ester Cerin; Terry L Conway; Marc A Adams; Lawrence D Frank; Michael Pratt; Deborah Salvo; Jasper Schipperijn; Graham Smith; Kelli L Cain; Rachel Davey; Jacqueline Kerr; Poh-Chin Lai; Josef Mitáš; Rodrigo Reis; Olga L Sarmiento; Grant Schofield; Jens Troelsen; Delfien Van Dyck; Ilse De Bourdeaudhuij; Neville Owen Journal: Lancet Date: 2016-04-01 Impact factor: 79.321
Authors: Florian Lipsmeier; Kirsten I Taylor; Timothy Kilchenmann; Detlef Wolf; Alf Scotland; Jens Schjodt-Eriksen; Wei-Yi Cheng; Ignacio Fernandez-Garcia; Juliane Siebourg-Polster; Liping Jin; Jay Soto; Lynne Verselis; Frank Boess; Martin Koller; Michael Grundman; Andreas U Monsch; Ronald B Postuma; Anirvan Ghosh; Thomas Kremer; Christian Czech; Christian Gossens; Michael Lindemann Journal: Mov Disord Date: 2018-04-27 Impact factor: 10.338
Authors: Brian L Graham; Irene Steenbruggen; Martin R Miller; Igor Z Barjaktarevic; Brendan G Cooper; Graham L Hall; Teal S Hallstrand; David A Kaminsky; Kevin McCarthy; Meredith C McCormack; Cristine E Oropez; Margaret Rosenfeld; Sanja Stanojevic; Maureen P Swanney; Bruce R Thompson Journal: Am J Respir Crit Care Med Date: 2019-10-15 Impact factor: 21.405
Authors: David Herzig; Prisca Eser; Thomas Radtke; Alina Wenger; Thomas Rusterholz; Matthias Wilhelm; Peter Achermann; Amar Arhab; Oskar G Jenni; Tanja H Kakebeeke; Claudia S Leeger-Aschmann; Nadine Messerli-Bürgy; Andrea H Meyer; Simone Munsch; Jardena J Puder; Einat A Schmutz; Kerstin Stülb; Annina E Zysset; Susi Kriemler Journal: Front Physiol Date: 2017-02-24 Impact factor: 4.566
Authors: Antonio de Arriba Muñoz; María Teresa García Castellanos; Mercedes Domínguez Cajal; Anunciación Beisti Ortego; Ignacio Martínez Ruiz; José Ignacio Labarta Aizpún Journal: J Am Med Inform Assoc Date: 2022-08-16 Impact factor: 7.942
Authors: Janine M Knijff; Euphemia C A M Houdijk; Daniëlle C M van der Kaay; Youri van Berkel; Luc Filippini; Frederik E Stuurman; Adam F Cohen; Gertjan J A Driessen; Matthijs D Kruizinga Journal: Digit Biomark Date: 2022-03-31
Authors: Matthijs D Kruizinga; Allison Moll; Ahnjili Zhuparris; Dimitrios Ziagkos; Frederik E Stuurman; Marianne Nuijsink; Adam F Cohen; Gertjan J A Driessen Journal: Respiration Date: 2021-05-18 Impact factor: 3.580
Authors: Sophie Huhn; Ina Matzke; Mara Koch; Hanns-Christian Gunga; Martina Anna Maggioni; Ali Sié; Valentin Boudo; Windpanga Aristide Ouedraogo; Guillaume Compaoré; Aditi Bunker; Rainer Sauerborn; Till Bärnighausen; Sandra Barteit Journal: Front Public Health Date: 2022-09-30
Authors: Pilar Rodríguez-Rubio; Laura Lacomba-Trejo; Selene Valero-Moreno; Inmaculada Montoya-Castilla; Marián Pérez-Marín Journal: Int J Environ Res Public Health Date: 2022-03-08 Impact factor: 3.390